EPISODE · Feb 26, 2024 · 28 MIN
MedShadow on FDA Drug Approvals and OTC Cold Medicines
from Get Connected
The Food and Drug Administration Advisory Panel has recently concluded that the decongestant phenylephrine, contained in many over-the-counter cold remedies for decades, is ineffective when taken orally. So, what is an effective over-the-counter option to fight seasonal flu, RSV, or Covid-19? We also asked our guest, Su Robotti, about the FDA drug approval process. Su Robotti is the Consumer Representative on the FDA Drug Risk and Advisory Council, and founder of MedShadow Foundation, the independent non-profit health news journalism site. For more, visit MedShadow.org.See omnystudio.com/listener for privacy information.
What this episode covers
The Food and Drug Administration Advisory Panel has recently concluded that the decongestant phenylephrine, contained in many over-the-counter cold remedies for decades, is ineffective when taken orally. So, what is an effective over-the-counter...
NOW PLAYING
MedShadow on FDA Drug Approvals and OTC Cold Medicines
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.